Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe Pneumonia,

More than 100 patients have been treated with avdoralimab in inflammation and oncology clinical trials with no new or unexpected safety signals …, More than 100 patients have been treated with avdoralimab in inflammation and oncology clinical trials with no new or unexpected safety signals …, Read More

Scroll to Top